Literature DB >> 4814607

Mechanism of action CDP-choline in parkinsonism.

S Manaka, K Sano, T Fuchinoue, H Sekino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4814607     DOI： 10.1007/bf01927720

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  5 in total

1.  [TREATMENT OF HEAD INJURIES WITH INTERMEDIATE SUBSTANCES OF THE METABOLIC CYCLE OF THE BRAIN. 1. THE USE OF CDP-CHOLINE].

Authors:  H MIYAKE; I HAYAKAWA; K TAKAKURA
Journal:  No To Shinkei       Date:  1964-10

2.  Effect of brain lesions on striatal monoamines in the cat.

Authors:  L J Poirier; P Singh; R Boucher; G Bouvier; A Olivier; P Larochelle
Journal:  Arch Neurol       Date:  1967-12

3.  [Effect of CDP-choline on glucose metabolism in the perfused brain].

Authors:  S Watanabe; S Kono; K Mitsunobu; T Suzuki; S Otsuki
Journal:  No To Shinkei       Date:  1971-06

4.  A rapid and sensitive procedure for the combined assay of noradrenaline, dopamine AND SEROTONIN IN A SINGLE BRAIN SAMPLE.

Authors:  G B Ansell; M F Beeson
Journal:  Anal Biochem       Date:  1968-05       Impact factor: 3.365

5.  [Treatment of head injuries with intermediate substances in the metabolic cycle of the brain. 2. Basic study on the metabolism of cytidine diphosphate choline].

Authors:  T Tsuchida; M Nagai; T Hoshino; S Kamano; H Miyake
Journal:  No To Shinkei       Date:  1967-10
  5 in total
  4 in total

1.  Interaction of CDP-choline with synaptosomal transport of biogenic amines and their precursors in vitro and in vivo in the rat corpus striatum.

Authors:  M Martinet; P Fonlupt; H Pacheco
Journal:  Experientia       Date:  1978-09-15

2.  Effect of cytidine(5')diphosphocholine (CDP-choline) on the total urinary excretion of 3-methoxy-4-hydroxyphenylglycol (MHPG) by rats and humans.

Authors:  I Lopez; G Coviella; J Agut; R J Wurtman
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

3.  Changes in brain striatum dopamine and acetylcholine receptors induced by chronic CDP-choline treatment of aging mice.

Authors:  R Giménez; J Raïch; J Aguilar
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

Review 4.  Neuroprotective properties of citicoline: facts, doubts and unresolved issues.

Authors:  Pawel Grieb
Journal:  CNS Drugs       Date:  2014-03       Impact factor: 5.749
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.